亚洲炎症性肠病诊断面临的挑战
The Challenge of Inflammatory Bowel Disease Diagnosis in Asia.
作者信息
Li Yue, Qian Jia-Ming
机构信息
Division of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
出版信息
Inflamm Intest Dis. 2017 Apr;1(4):159-164. doi: 10.1159/000448384. Epub 2016 Aug 19.
Abstract
BACKGROUND
The current major clinical challenge relates to the accurate diagnosis of inflammatory bowel disease (IBD) in Asian countries with a high background prevalence of infections.
SUMMARY
The diagnosis of Crohn's disease in geographical areas where tuberculosis is endemic poses a major diagnostic challenge.
KEY MESSAGES
Infections can mimic IBD and complicate the course of existing IBD. Limited availability of diagnostic modalities and health service may delay diagnosis. A multidisciplinary approach, continuous medical education, and academic activities may warrant an accurate diagnosis of IBD.
摘要
背景
在感染背景患病率较高的亚洲国家，目前主要的临床挑战涉及炎症性肠病（IBD）的准确诊断。
总结
在结核病流行的地理区域，克罗恩病的诊断构成了一项重大的诊断挑战。
关键信息
感染可能模仿IBD并使现有IBD的病程复杂化。诊断方式和医疗服务的可及性有限可能会延迟诊断。多学科方法、持续医学教育和学术活动可能有助于IBD的准确诊断。
相似文献
1
The Challenge of Inflammatory Bowel Disease Diagnosis in Asia.亚洲炎症性肠病诊断面临的挑战
Inflamm Intest Dis. 2017 Apr;1(4):159-164. doi: 10.1159/000448384. Epub 2016 Aug 19.
2
Diagnosis of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization for Crohn's and Colitis (AOCC) meeting in Seoul.亚洲炎症性肠病的诊断：在首尔举行的第二届亚洲克罗恩病和结肠炎组织（AOCC）会议上进行的一项跨国网络调查结果
Intest Res. 2016 Jul;14(3):224-30. doi: 10.5217/ir.2016.14.3.224. Epub 2016 Jun 27.
3
Management consensus of inflammatory bowel disease for the Asia-Pacific region.亚太地区炎症性肠病管理共识
J Gastroenterol Hepatol. 2006 Dec;21(12):1772-82. doi: 10.1111/j.1440-1746.2006.04674.x.
4
The Same Intestinal Inflammatory Disease despite Different Genetic Risk Factors in the East and West?东西方遗传风险因素不同，肠道炎症性疾病却相同？
Inflamm Intest Dis. 2016 Jul;1(2):78-84. doi: 10.1159/000446625. Epub 2016 Jul 15.
5
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia.亚洲克罗恩病和结肠炎组织与亚太消化病学会炎症性肠病亚洲地区医学管理和监测实践建议。
J Gastroenterol Hepatol. 2021 Mar;36(3):637-645. doi: 10.1111/jgh.15185. Epub 2020 Jul 29.
6
Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul.亚洲炎症性肠病的治疗：在首尔举行的第二届亚洲克罗恩病和结肠炎组织（AOCC）会议上进行的一项基于网络的多国调查结果
Intest Res. 2016 Jul;14(3):231-9. doi: 10.5217/ir.2016.14.3.231. Epub 2016 Jun 27.
7
Asian perspectives in the management of inflammatory bowel disease: findings from a recent survey.亚洲视角下炎症性肠病的管理：一项近期调查的结果。
J Gastroenterol Hepatol. 2010 Jan;25(1):183-93. doi: 10.1111/j.1440-1746.2009.06024.x. Epub 2009 Nov 19.
8
Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia.亚洲资源有限环境下炎症性肠病的诊断和管理难题。
Lancet Gastroenterol Hepatol. 2020 Dec;5(12):1076-1088. doi: 10.1016/S2468-1253(20)30299-5.
9
How Does the Epidemiology of Inflammatory Bowel Disease Differ between East and West? A Korean Perspective.炎症性肠病在东西方的流行病学差异如何？韩国视角。
Inflamm Intest Dis. 2017 Nov;2(2):95-101. doi: 10.1159/000454712. Epub 2017 Jan 14.
10
Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus--Part 1).《亚太地区克罗恩病共识声明》。第1部分：定义、诊断与流行病学（亚太地区克罗恩病共识——第1部分）
J Gastroenterol Hepatol. 2016 Jan;31(1):45-55. doi: 10.1111/jgh.12956.
引用本文的文献
1
Long noncoding RNAs and circular RNAs as potential diagnostic biomarkers of inflammatory bowel diseases: a systematic review and meta-analysis.长链非编码 RNA 和环状 RNA 作为炎症性肠病潜在诊断生物标志物的系统评价和荟萃分析。
Front Immunol. 2024 Mar 8;15:1362437. doi: 10.3389/fimmu.2024.1362437. eCollection 2024.
2
A Shortened Diagnostic Interval and Its Associated Clinical Factors and Related Outcomes in Inflammatory Bowel Disease Patients from a Cohort Study in China.一项来自中国队列研究的炎症性肠病患者缩短的诊断间隔及其相关临床因素和相关结局
J Inflamm Res. 2024 Jan 18;17:387-398. doi: 10.2147/JIR.S434673. eCollection 2024.
3
IBD barriers across the continents - East Asia.各大洲的炎症性肠病障碍——东亚地区
Therap Adv Gastroenterol. 2023 Nov 22;16:17562848231212089. doi: 10.1177/17562848231212089. eCollection 2023.
4
Identification and Validation of the Diagnostic Markers for Inflammatory Bowel Disease by Bioinformatics Analysis and Machine Learning.基于生物信息学分析和机器学习的炎症性肠病诊断标志物的鉴定和验证。
Biochem Genet. 2024 Feb;62(1):371-384. doi: 10.1007/s10528-023-10422-9. Epub 2023 Jun 23.
5
Development of Machine Learning Model to Predict the 5-Year Risk of Starting Biologic Agents in Patients with Inflammatory Bowel Disease (IBD): K-CDM Network Study.用于预测炎症性肠病（IBD）患者开始使用生物制剂的5年风险的机器学习模型的开发：K-CDM网络研究。
J Clin Med. 2020 Oct 26;9(11):3427. doi: 10.3390/jcm9113427.
6
Optimizing the multidimensional aspects of the patient-physician relationship in the management of inflammatory bowel disease.优化炎症性肠病管理中患者与医生关系的多维度方面。
Intest Res. 2018 Oct;16(4):509-521. doi: 10.5217/ir.2018.00074. Epub 2018 Oct 25.
7
Temporal trends in the misdiagnosis rates between Crohn's disease and intestinal tuberculosis.克罗恩病与肠结核误诊率的时间趋势。
World J Gastroenterol. 2017 Sep 14;23(34):6306-6314. doi: 10.3748/wjg.v23.i34.6306.
本文引用的文献
1
Intestinal tuberculosis and Crohn's disease: challenging differential diagnosis.肠结核与克罗恩病：具有挑战性的鉴别诊断
J Dig Dis. 2016 Mar;17(3):155-61. doi: 10.1111/1751-2980.12324.
2
The differentiation of amebic colitis from inflammatory bowel disease on endoscopic mucosal biopsies.通过内镜下黏膜活检鉴别阿米巴结肠炎与炎症性肠病。
Indian J Pathol Microbiol. 2015 Oct-Dec;58(4):427-32. doi: 10.4103/0377-4929.168880.
3
Differences in clinical features of Crohn's disease and intestinal tuberculosis.克罗恩病与肠结核临床特征的差异。
World J Gastroenterol. 2015 Mar 28;21(12):3650-6. doi: 10.3748/wjg.v21.i12.3650.
4
Computed tomographic enterography adds value to colonoscopy in differentiating Crohn's disease from intestinal tuberculosis: a potential diagnostic algorithm.计算机断层扫描小肠造影在鉴别克罗恩病与肠结核方面比结肠镜检查更具价值：一种潜在的诊断算法。
Endoscopy. 2015 Apr;47(4):322-9. doi: 10.1055/s-0034-1391230. Epub 2015 Feb 12.
5
Discriminating potential of extraintestinal systemic manifestations and colonoscopic features in Chinese patients with intestinal Behçet's disease and Crohn's disease.中国肠白塞病和克罗恩病患者肠外全身表现及结肠镜特征的鉴别潜力
Chin Med J (Engl). 2015 Jan 20;128(2):233-8. doi: 10.4103/0366-6999.149213.
6
The incidence of inflammatory bowel disease in Northern China: a prospective population-based study.中国北方炎症性肠病的发病率：一项基于人群的前瞻性研究。
PLoS One. 2014 Jul 16;9(7):e101296. doi: 10.1371/journal.pone.0101296. eCollection 2014.
7
Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn's disease in Asians.系统评价与荟萃分析：亚洲人群中γ-干扰素释放试验及抗酿酒酵母抗体在鉴别肠结核与克罗恩病中的准确性
J Gastroenterol Hepatol. 2014 Sep;29(9):1664-70. doi: 10.1111/jgh.12645.
8
Diagnostic role of computed tomographic enterography differentiating crohn disease from intestinal tuberculosis.计算机断层扫描小肠造影在鉴别克罗恩病与肠结核中的诊断作用
J Comput Assist Tomogr. 2013 Sep-Oct;37(5):834-9. doi: 10.1097/RCT.0b013e31829e0292.
9
First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease.中国内地首项基于人群的炎症性肠病发病研究：“西方”疾病的出现。
Inflamm Bowel Dis. 2013 Aug;19(9):1839-45. doi: 10.1097/MIB.0b013e31828a6551.
10
Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study.基于亚太克罗恩病和结肠炎流行病学研究结果的炎症性肠病的发病率和表型。
Gastroenterology. 2013 Jul;145(1):158-165.e2. doi: 10.1053/j.gastro.2013.04.007. Epub 2013 Apr 9.
Zotero 插件